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Background: KwaZulu-Natal is the South African province worst affected by HIV and the focus of early modeling
studies investigating strategies of antiretroviral treatment (ART) delivery. The reality of antiretroviral roll-out through
primary care has differed from that anticipated and real world data are needed to inform the planning of further
scaling up of services. We investigated the factors associated with uptake of antiretroviral treatment through a
primary healthcare system in rural South Africa.
Methods: Detailed demographic, HIV surveillance and geographic information system (GIS) data were used to
estimate the proportion of HIV positive adults accessing antiretroviral treatment within northern KwaZulu-Natal,
South Africa in the period from initiation of antiretroviral roll-out until the end of 2008. Demographic, spatial and
socioeconomic factors influencing the likelihood of individuals accessing antiretroviral treatment were explored
using multivariable analysis.
Results: Mean uptake of ART among HIV positive resident adults was 21.0% (95%CI 20.1-21.9). Uptake among HIV
positive men (19.2%) was slightly lower than women (21.8%, P = 0.011). An individual’s likelihood of accessing ART
was not associated with level of education, household assets or urban/rural locale. ART uptake was strongly
negatively associated with distance from the nearest primary healthcare facility (aOR = 0.728 per square-root
transformed km, 95%CI 0.658-0.963, P = 0.002).
Conclusions: Despite concerns about the equitable nature of antiretroviral treatment rollout, we find very few
differences in ART uptake across a range of socio-demographic variables in a rural South African population.
However, even when socio-demographic factors were taken into account, individuals living further away from
primary healthcare clinics were still significantly less likely to be accessing ART
Background
Recent years have seen substantial progress being made
in the roll-out of antiretroviral therapy (ART) to popula-
tions in sub-Saharan Africa [1]. Many challenges remain
in achieving access to antiretroviral treatment for all
those in need, particularly in more rural parts of sub-
Saharan Africa where often there is weak, if any, public
health infrastructure. In areas with hyperendemic HIV
infection, delivery of ART is seen as an important com-
ponent of multi-faceted prevention measures [2] and
increasingly attention is focused on whether antiretrovir-
als could be targeted more widely to have a direct
impact on population HIV transmission [3]. Such a
strategy, if implemented, would require substantially
higher levels of antiretroviral treatment coverage than
current targets and a detailed understanding of the
extent to which current systems are able to deliver ART
is increasingly important.
South Africa carries the world’s greatest burden of
HIV infection, with estimates that it is home to approxi-
mately 17% of the world’s HIV positive population [4].
Worst affected within South Africa is the province of
KwaZulu-Natal, home to approximately 1.5 million HIV
positive individuals and where HIV prevalence is greater
than 50% in some age groups [5]. The province is
mostly rural [6] and despite a decentralized primary
healthcare system, many patients have difficulty travel-
ling to their nearest healthcare facility [7]. The chal-
lenges posed by ART delivery in the region were the
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any medium, provided the original work is properly cited.subject of early modeling exercises prior to antiretroviral
roll-out, with a particular focus on equity of ART deliv-
ery [6,8,9]. The realities of roll-out have been more
varied than those models originally envisaged and ART
is not routinely available in many primary care facilities.
Here we describe the evolution of antiretroviral treat-
ment through a primary healthcare service in a rural
South African setting where at a sub-district level there
exists substantial geographical heterogeneity in HIV pre-
valence [10]. We use detailed demographic, HIV surveil-
lance and geographical information systems (GIS) data
to estimate the proportion of the population accessing
ART and explore geographical variation in ART uptake
across the study area. In addition, we investigate
whether socioeconomic and geographic factors are asso-
ciated with the likelihood of ART uptake.
Methods
The study was carried out in the Hlabisa sub-district in
Umkhanyakude district, northern KwaZulu-Natal. The
district is the third most deprived in South Africa [11].
Since 1999, the Africa Centre for Health and Population
Studies http://www.africacentre.ac.za has carried out
established a demographics u r v e i l l a n c ea r e a( D S A )
within a portion of this sub-district. The DSA has a
population of approximately 87,000 within an area of
438 km
2 including deep rural areas, a township and
peri-urban informal settlements. At any point in time,
one-third of the population under surveillance, who
although members of households in the area, do not
physically reside in the surveillance area [11].
Since the beginning of 2003, HIV infection status of
adults has been determined through a separate annual
sero-surveillance [12]. HIV prevalence in this population
has steadily increased since the early 1990s [13,14] to
21·5% in 2004. Overall, 27% of female and 13·5% of
male residents were HIV-infected in 2004, HIV preva-
lence was highest in the five-year age groups of 25-29
years in women (51%) and 30-34 years in men (44%)
[15]. The geographical distribution of HIV infection is
not uniform and ranges from <10% in some of the more
rural parts of the surveillance area to ≥35% in some of
the high density settlements located along the National
Road [10].
Delivery of care and antiretroviral treatment
The Hlabisa HIV treatment and care program has been
described in detail elsewhere [16]. Briefly, the program
covers the whole sub-district of Hlabisa, an area with a
population of approximately 228,000 people. Six of the
clinics in the sub-district lie within the demographic sur-
veillance area described above; the DSA covers approxi-
mately 40% of the population in the sub-district and is
the focus of this analysis. Since 2004, ART has been
provided free of charge through government clinics in
the area. Public sector provision has undergone rapid
expansion [17], aided in the area of study by NGO sup-
port. The service began in late 2004 based at the district
hospital (Phase 1). In August 2005, provision was added
to a community health centre in the township within the
area of surveillance and all primary healthcare clinics
began monitoring CD4 counts and providing antiretro-
viral treatment (Phase 2). By December 2006, 14 primary
healthcare facilities had clinician support for the care and
treatment of patients requiring ART (Phase 3).
Patients were eligible for ART based on standardised
national guidelines [18]. Prior to initiation of antiretro-
viral treatment patients were monitored with periodic
CD4 counts. First line ART was a standardised combi-
nation of two nucleoside reverse transcriptase inhibitors
(NRTIs; stavudine and lamivudine) and one non-nucleo-
side reverse transcriptase inhibitors (NNRTIs; efavirenz
or nevirapine). Following ART initiation, patients were
reviewed monthly by a counsellor and are offered CD4
counts and viral load testing on a 6 monthly basis.
Estimation of numbers of adults receiving ART by
catchment area
The demographic surveillance area was divided into six
clinic catchments using a validated GIS model of travel
time to clinic described previously [19]. Individuals age
15 or older initiating HAART in the sub-district (or
transferring in their care) between program inception in
August 2004 and 31
st December 2008 were eligible for
inclusion in the study. Individuals were excluded if they
were lost to follow-up (did not attend for three consecu-
tive appointments), died or were transferred out of the
program. The catchments provide an intuitive means of
dividing up the study area into sub-areas and did not
exclude patients living in these areas who were getting
their ART elsewhere in the sub-district. To allow com-
parison of where patients actually receive care with
where they would be expected to receive care based on
physical proximity to clinics, patients were assigned
directly to a clinic catchment in the surveillance area
using the GIS location of their homestead of residence
(obtained through direct linkage to a demographic data-
base). Strict matching criteria were applied by dedicated
data handling staff which meant a person was only
linked either by their unique South African identifica-
tion number, or if both first and surnames matched.
The remaining patients (who reportedly lived in the sur-
veillance area but could not be directly linked) were
assigned to clinic catchments using the local area
(neighbourhood or izigodi) information provided by the
patient. In isolated cases where the local area spanned
multiple clinic catchments, patients were stochastically
assigned to one of the overlapping catchments according
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mission was received from the local Department of
Health and University of KwaZulu Natal (E134/06) and
verbal consent was obtained from individuals participat-
ing in demographic surveillance. Individual written
informed consent was given for participation in HIV
surveillance. Because the demographic surveillance col-
lects information on both residents and non-residents of
households in the surveillance area [11], we quantified
the proportion of ART patients (among linked patients)
who were not normally resident in the surveillance area
but who returned periodically to visit their families and
to receive ART.
The underlying numbers of individuals in the popula-
tion with HIV were estimated from surveillance data.
Because the population consenting to an HIV test differs
from the total population for testing, we produced age-
sex standardised (to the eligible population in each
catchment area) estimates of the total number of HIV
positive resident adults in each clinic catchment. We
then used to this information to estimate the proportion
of ART uptake by clinic catchment (number of residents
adults receiving ART/number of resident adults with
HIV infection).
Analysing the factors associated with ART uptake
To assess antiretroviral treatment uptake across socio-
economic criteria, we used individuals in the popula-
tion-based 2008 cohort to compare HIV positive resi-
dents (≥15 years of age) on antiretroviral treatment (N
= 1,251) with HIV positive residents identified by the
population-based surveillance who were not recorded as
receiving ART (N = 1,033) using a binary logistic regres-
sion (weighted according to the characteristics of the
underlying HIV positive population under surveillance).
In addition to age and sex, co-variates studied were
years of education, household asset index, urban/rural/
peri-urban locale and Euclidean distance to the nearest
ART clinic (square-root transformed km). Household
asset index was calculated using previously described
principal components analysis [15]. The 2007 household
socio-economic variables used in the analysis are col-
lected routinely by the surveillance system using metho-
dology described previously [11]. Statistical and spatial
analysis were performed using STATA v 10 (StataCorp,
USA) and Mapinfo 10.0 (Rockware, USA).
Results
The total number of patients ever initiated on ART in
the program increased to 7,576 by the end of 2008 with
6,354 patients actively on ART (67% were female). Of
those actively receiving ART, 2,412 were attending one
of the six pre-defined clinic catchments (see Table 1).
An estimated 1660 (69%) of these were resident in the
six catchment areas whilst the remainder were migrants
who ordinarily lived elsewhere but returned to the area
frequently. Seventy four percent of patients within the
DSA were matched directly to clinic catchment areas,
twenty six percent allocated as described in methods.
The median distance travelled by a patient in the pro-
gram living in the study area to access ART fell from
34.2 km when treatment was only available at the dis-
trict hospital, to 8.5 km when treatment was available
through the community healthcare facility, to 3.1 km
when treatment was available through all primary
healthcare clinics. By the end of 2008, 70% of patients
received treatment from their nearest clinic (defined on
the basis of estimated travel time [20]).
The mean population uptake of ART among HIV
positive residents was 21.0% (95% C.I. = 20.1 - 21.9) and
ART uptake in different clinic catchment areas ranged
from 18.3 to 27.7% (Figure 1). The highest uptake was
found in one of the more rural catchment areas. Overall,
antiretroviral treatment uptake was slightly higher in
HIV-positive women (21.8%, 95% CI = 20.7 - 22.9%) by
comparison to HIV positive men (19.2%, 95 CI = 17.7 -
20.8%, p-value of difference = 0.011). Uptake was lowest
in the youngest age-groups where the majority of HIV
infections are recently acquired. In this population,
uptake of ART in males lagged behind females probably














1 Rural 90 62 17.3 250 24.7 (19.9 - 29.5)
2 Rural 187 129 15.1 463 27.7 (24.1 - 31.3)
3 Urban/peri-
urban
1063 732 26.7 3372 21.6 (20.4 to 22.9)
4 Rural 171 118 19.3 504 23.2 (20.0 - 26.6)
5 Peri-urban 488 336 23.1 1831 18.3 (16.7 - 19.9)
6 Peri-urban/rural 413 284 18.3 1475 19.2 (17.4 - 21.0)
Total 2412 1660 22.1 7895 21.0 (20.2 - 21.8)
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begins to approach parity in the 40-45 year age group.
ART uptake was highest among HIV positive females in
the 50-54 year age group (45%) and thereafter declined
to 20% in the ≥60 age group. Males showed a similar
pattern with 36% of 50-54 year old HIV positive males
on ART. The seemingly relatively high coverage of ART
in the very young and old age groups in HIV positive
males likely reflects the instability in these estimates due
to small numbers of patients on treatment.
The characteristics of individuals in the analysis
comparing linked HIV positive patients on ART
against infected individuals not on ART is given (Table
2). An multi-variable analysis exploring factors influen-
cing an individual’s likelihood of accessing ART (com-
paring the linked HIV positive patients on ART
against infected individuals not on ART) showed that
HIV positive men were less likely to access antiretro-
viral treatment in comparison to women, but the dif-
ference was not significant (Table 3). As would be
expected on the basis of ART need, age was a highly
significant predictor of uptake - the median was 30.5
year for the untreated group and 36.3 for the group on
ART. The adjusted odds of accessing ART remained
high throughout the ages 30-54 and peaked in the 50-
54 year age group.
Only rural/urban locale was a significant predictor of
uptake in univariate analysis but in multivariable analy-
sis the key predictor of ART uptake among the infected
population was distance to the nearest health facility.
ART uptake amongst HIV positive individuals within 1
km of a clinic was estimated to be 25.9% (95% CI; 23.1-
28.8). The likelihood of accessing ART decreased by
27% with every square-root transformed km to nearest
health facility. This equates to an initial steep decrease
in likelihood of accessing ART with increasing distance
(Figure 2) but the rate of decrease attenuates as distance
increases. At just 4.78 km (unadjusted = 3.04 km) from
the nearest clinic the odds of an HIV positive individual
accessing ART are half those of an infected person liv-
ing next door to a health facility holding all other fac-
tors constant (Figure 3). Approximately 31% of the
study area (containing 19% of the population) is further
than 4.78 km away from the nearest health facility.
Educational attainment, household wealth quintile and
urban/rural locale did not significantly affect the likeli-
hood of an HIV positive individual receiving ART in the
multi-variate analysis (Table 3). In addition, we found
no relationship between school attainment and uptake
among infected individuals.
Discussion
This represents one of the largest studies to date investi-
gating factors related to antiretroviral uptake in an Afri-
can setting. Through linkage of the population-based
HIV surveillance data to the Hlabisa treatment and care
program [16] we have been able to examine in detail the
factors associated with ART uptake in a rural area.
Despite questions raised [21,8,22] around the ability of
ART programs in rural settings to reach vulnerable
populations, we find remarkably little socio-demographic
difference between the HIV positive populations acces-
sing/not accessing ART. We do, however, find that phy-
sical distance from primary health clinics is a significant
obstacle to accessing ART even when other socio-demo-
graphic factors are taken into account. Our data esti-
mate ART uptake within 1 km of a clinic to be 25.9%
(compared to 21.0% overall), falling rapidly with increas-
ing distance from a clinic. This is despite an accelerated
attempt towards decentralization of services in the area
in question. Put more starkly, at distances of only 5 km
from the nearest clinic, the odds of an HIV positive
individual accessing ART are less than half those of an
infected person living immediately next to a health facil-
ity holding all other factors constant. Contrary to expec-
tation, no effect was seen due to level of education or
measures of household wealth.
In the region in question, the provision of ART through
primary healthcare facilities reduced the median distance
that patients travel to access ART from 34.2 km to 3.1 km.
Figure 1 Mean uptake of antiretroviral treatment (%) by HIV
positive adults in adjacent clinic catchment areas.
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Not on ART
(%)





15-19 (n = 143) 88.8 [79.4,94.2] 11.2 [5.8,20.6]
20-24 (n = 312) 79.5 [74.8,83.5] 20.5 [16.5,25.2]
25-29 (n = 382) 59.2 [51.8,66.2] 40.8 [33.8,48.2]
30-34 (n = 385) 43.6 [37.8,49.7] 56.4 [50.3,62.2]
35-40 (n = 330) 39.7 [33.3,46.4] 60.3 [53.6,66.7]
40-45 (n = 240) 43.3 [38.1,48.7] 56.7 [51.3,61.9]
45-50 (n = 194) 50.5 [44.5,56.5] 49.5 [43.5,55.5]
50-54 (n = 155) 41.9 [33.6,50.8] 58.1 [49.2,66.4]
55-60 (n = 73) 54.8 [48.6,60.8] 45.2 [39.2,51.4]
> 60 (n = 70) 62.9 [52.2,72.4] 37.1 [27.6,47.8] < 0.001
Sex
FEM (n = 1,757) 56 [48.4,63.3] 44 [36.7,51.6]
MAL (n = 527) 50.7 [41.5,59.8] 49.3 [40.2,58.5] 0.031
Years of Education Attained
0 (n = 334) 52.4 [46.1,58.6] 47.6 [41.4,53.9]
1 (n = 25) 48 [30.3,66.2] 52 [33.8,69.7]
2 (n = 46) 56.5 [40.1,71.7] 43.5 [28.3,59.9]
3 (n = 93) 52.7 [42.6,62.5] 47.3 [37.5,57.4]
4 (n = 89) 49.4 [39.7,59.2] 50.6 [40.8,60.3]
5 (n = 89) 47.2 [38.1,56.5] 52.8 [43.5,61.9]
6 (n = 94) 47.9 [36.6,59.3] 52.1 [40.7,63.4]
7 (n = 177) 57.1 [48.1,65.6] 42.9 [34.4,51.9]
8 (n = 182) 59.9 [46.8,71.7] 40.1 [28.3,53.2]
9 (n = 173) 62.4 [47.2,75.6] 37.6 [24.4,52.8]
10 (n = 290) 57.6 [48.4,66.3] 42.4 [33.7,51.6]
11 (n = 238) 60.5 [47.6,72.1] 39.5 [27.9,52.4]
12 (n = 454) 50.4 [44.0,56.9] 49.6 [43.1,56.0] 0.062
Assets Index (1 = poorest)
1 (n = 403) 54.8 [47.5,62.0] 45.2 [38.0,52.5]
2 (n = 440) 56.1 [47.9,64.0] 43.9 [36.0,52.1]
3 (n = 495) 56 [47.8,63.8] 44 [36.2,52.2]
4 (n = 503) 55.5 [46.8,63.8] 44.5 [36.2,53.2]
5 (n = 381) 51.2 [43.5,58.8] 48.8 [41.2,56.5]
Missing (n = 62) 51.6 [35.0,67.8] 48.4 [32.2,65.0] 0.709
Urban/Rural
Peri-Urban (n = 822) 51.5 [41.6,61.2] 48.5 [38.8,58.4]
Rural (n = 1,296) 58.2 [49.7,66.2] 41.8 [33.8,50.3]
Urban (n = 166) 44.6 [35.1,54.5] 55.4 [45.5,64.9] < 0.001
Distance to Clinic
< 1 Km (n = 306) 45.4 [37.9,53.2] 54.6 [46.8,62.1]
1-2 Km (n = 597) 52.8 [45.0,60.4] 47.2 [39.6,55.0]
2-3 Km (n = 457) 56.5 [49.0,63.6] 43.5 [36.4,51.0]
3-4 Km (n = 378) 52.6 [45.0,60.2] 47.4 [39.8,55.0]
4-5 Km (n = 228) 61.8 [52.8,70.2] 38.2 [29.8,47.2]
> 5 Km (n = 318) 62.6 [52.4,71.8] 37.4 [28.2,47.6] < 0.001
Total (n = 2,284) 54.8 [48.5,60.9] 45.2 [39.1,51.5]
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estimates of 20 km or upwards used in early modelling of
resource allocation [9]. To achieve more uniform levels of
ART uptake, consideration wi l lh a v et ob eg i v e nt ot h e
cost-effectiveness of alternative ART delivery strategies
(including, but not limited to, mobile treatment centres
and more comprehensive home support services). Our
results suggest that by making ART services more physi-
cally accessible, a relative increase in population ART
uptake approaching 20% could be achieved.
The study area differs from many others in having
rapidly decentralised ART delivery to primary care. We
find that through this system it was possible to deliver
ART to approximately 21% of the total HIV positive
adult population over limited period of time within a
relatively poor, rural area. This proportion accessing
ART exceeds the target of 15% widely used in estimates
of ART need at the beginning of roll-out [23] (and
Table 3 Results of a logistic regression comparing the characteristics of HIV positive residents (≥15 years of age) on
treatment (N = 1,251) with HIV positive residents who were not recorded as receiving treatment (N = 1,033).
Participants(n = 2,284)
Covariate Unadjusted OR* P≥|z| Adjusted OR* P≥|z| 95% CI
Sex
F* 1 1
M 1.098 0.368 0.875 0.216 (0.708 to 1.081)
Age
15-19* 1 1
20-24 1.947 0.030 2.001 0.025 (1.092 to 3.669)
25-29 4.904 < 0.001 4.998 < 0.001 (2.820 to 8.859)
30-34 10.499 < 0.001 11.065 < 0.001 (6.230 to 19.653)
35-40 11.536 < 0.001 12.525 < 0.001 (6.949 to 22.574)
40-45 9.610 < 0.001 10.579 < 0.001 (5.742 to 19.494)
45-50 7.944 < 0.001 9.297 < 0.001 (4.960 to 17.426)
50-54 11.480 < 0.001 14.020 < 0.001 (7.309 to 26.890)
55-60 5.564 < 0.001 6.726 < 0.001 (3.169 to 14.276)
≥60 4.632 < 0.001 5.834 < 0.001 (2.737 to 12.437)
Years Of Education
per unit 0.987 0.213 1.022 0.128 (0.995 to 1.063)
Assets Index
1 (poorest)* 1 1
2 0.954 0.748 0.932 0.649 (0.688 to 1.262)
3 0.921 0.564 0.842 0.258 (0.624 to 1.135)
4 0.983 0.904 0.829 0.237 (0.607 to 1.131)
5 (wealthiest) 1.115 0.475 0.984 0.927 (0.702 to 1.379)
(Missing) 1.035 0.906 0.684 0.211 (0.377 to 1.241)
Urban/Rural Status
Peri-urban 0.883 0.498 1.042 0.838 (0.699 to 1.554)
Rural 0.654 0.017 0.941 0.768 (0.628 to 1.410)
Urban* 1 1
SqrtKmToNearestClinic
per unit 0.671 < 0.001 0.728 0.002 (0.618 to 0.990)
* Weighted according to the characteristics of the underlying HIV positive population
Figure 2 Overall likelihood of accessing antiretroviral
treatment with distance from nearest primary healthcare
facility (km).
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gets are dynamic in areas where antiretroviral roll-out is
maturing and new infection rates remain high [24], and
can differ between regions [25] and for these reasons we
focus here on the proportion of infected individuals
accessing ART. Recently we have started to model the
epidemic in this area using STDSIM [26]. Initial esti-
mates indicate that at the end of 2008, the 21% uptake
of ART among the HIV positive population translates
into a coverage figure of approximately 66% (Jan Honte-
lez, pers comm).
As well as the overall proportion of a population
accessing ART, there are different notions of ethical
treatment delivery. One principle highlighted in pre-
v i o u sw o r ki se g a l i t a r i a ne q u i ty (distribution of health-
care equally among groups that differ in socioeconomic
circumstances) [8,22,27]. The observation that the pro-
file of household assets for those accessing ART does
not differ significantly from that of the population
infected with HIV, suggests that the ethical principle of
egalitarian equity is being observed with regard to
wealth. Locally, individuals in the poorest households
are no less likely to utilize ART than those in wealthier
ones (either univariately or holding all other factors
constant). Contrary to recent reports from other
settings suggesting large gender disparities in access to
HIV treatment and care [28,29], we show that HIV
positive men are only slightly less likely to have
accessed ART in comparison to women. However, this
is not to say that significant sex differences do not exist,
for example local data suggests that amongst individuals
not yet eligible for HAART, retention rates within the
program are poorer for men [30] and that men are
more likely to access ART programs with evidence of
advanced disease [17]. The significant differences in age
observed are expected and a consequence of the time
delay between HIV infection and progression to the
point of ART eligibility which studies find to be quite
consistent across sub-Saharan Africa [31].
The speed with which services can be scaled-up has to
be balanced against the quali t yo fc a r ei ti sp o s s i b l et o
deliver and ultimately, the most important outcomes of
widespread ART delivery will be the impact on popula-
tion mortality and ongoing HIV transmission. Estimates
from the study area suggest an important early impact on
population mortality, but that HIV remains the leading
cause of death [32], and HIV incidence remains high [5].
Local data suggests that in this early phase of ART deliv-
ery at least, outcomes for ART showed no evidence of
decline [17] and are broadly similar to those described
elsewhere [33], though such data is difficult to compare
between sites [34]. The development of services in the
area of study was support by local NGOs with PEPFAR
funding which is not the case in many other settings.
Whether such outcomes can be maintained as services
reach capacity is an important consideration, particularly
as discussions begin around the possibility of reaching far
higher levels of ART uptake, both in the implementation
of new WHO treatment guidelines and as a means to
decrease rates of HIV transmission [3].
There are some limitations to the work presented
here; the imperfect linkage between ART program and
HIV surveillance data translates into relatively small
false negative ratio of 6.5% (those on ART but not
designated as such) in the individual-based risk factor
analysis. This could result in a slight ascertainment bias
of the results towards the null hypothesis. However, this
could not create a spurious positive finding and would
be unlikely to impact on any of the “null” findings (sex,
education, household wealth, urban/rural locale) as none
of these predictors bordered on statistical significance.
We were not able to measure the small numbers of
individuals accessing ART through non-governmental
sources which might include family practitioners or
other care providers in the area. During the period in
question, the proportion of individuals receiving care in
these settings was less than 5% of the total number.
These factors mean that estimates of ART uptake pro-
vided here should be taken to refer to public sector
Figure 3 Likelihood (OR) for HIV positive adults accessing ART
as a function of distance from nearest primary healthcare
facility.
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likely to be a lower estimate for the total population
uptake of antiretroviral treatment overall, but that the
underestimate is likely to be small. Such methodological
issues will be important when comparing data from dif-
ferent settings and one interesting and unexpected find-
ing of this study has been the large proportion (31%) of
individuals receiving ART in the sub-district who are
not normally resident in the area (migrants) but return
frequently to be with their families and receive their
ART. Failure to account for this could lead to inflated
uptake estimates.
Strategies considering the wider use of antiretrovirals
for preventing HIV transmission will require not only
much higher levels of treatment uptake, but also high
levels of VCT uptake. We have not attempted to address
the overall uptake of VCT testing and knowledge of
H I Vs t a t u sa si n d i v i d u a ld a t ai sn o tc o l l e c t e dl o c a l l y
within government services. However, some minimum
estimate of the numbers of HIV positive aware of their
status can be derived from the number of different indi-
viduals accessing care (as determined by unique indivi-
duals attending for CD4 testing) before eligibility for
ART compared to those receiving ART. Locally that
ratio is approximately 1:1 suggesting a minimum bound
for the proportion of the HIV positive population acces-
sing care of at least 40%. The true level of VCT uptake
is likely to be higher, to some extent for the reasons
described above in relation to estimates of treatment
uptake, but also because a significant number of indivi-
duals are probably lost from services prior to CD4 test-
ing following a positive VCT result.
Conclusions
Taken overall this work demonstrates the feasibility of
delivering antiretroviral treatment to a significant pro-
portion of the HIV positive population through a decen-
tralised primary care system. Through this system it was
possible to achieve equitable ART delivery, at least for
measures based on household wealth and educational
attainment. However, despite this process of decentrali-
sation, physical access to ART remains a challenge to be
overcome.
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